DENVER INVESTMENT ADVISORS LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$68,000
+4.6%
10,111
-10.2%
0.00%0.0%
Q3 2015$65,000
-31.6%
11,258
-3.3%
0.00%
-25.0%
Q2 2015$95,000
-21.5%
11,646
-21.4%
0.00%0.0%
Q1 2015$121,000
-12.9%
14,826
-2.1%
0.00%0.0%
Q4 2014$139,00015,1400.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Defender Capital, LLC. 581,100$2,324,0002.21%
Round Table Services, LLC 339,391$1,358,0000.52%
ARK Investment Management 1,885,641$7,543,0000.31%
WASATCH ADVISORS LP 5,337,930$21,352,0000.28%
Cedar Brook Financial Partners, LLC 41,500$166,0000.10%
Unified Trust Company, N.A. 13,716$54,0000.05%
Virtus ETF Advisers LLC 60,398$242,0000.04%
OXFORD ASSET MANAGEMENT LLP 394,703$1,579,0000.04%
FOX RUN MANAGEMENT, L.L.C. 14,465$58,0000.03%
BREWIN DOLPHIN LTD 59,123$236,4920.03%
View complete list of INOVIO PHARMACEUTICALS INC shareholders